Alvin Ho‐Kwan Cheung, Chris Ho‐Lam Hui, Kit Yee Wong, Xiaoli Liu, Bonan Chen, Wei Kang & Ka Fai To. (2022) Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis. International Journal of Cancer 152:8, pages 1510-1525.
Crossref
Jong Shin, Hannan Mir, Maaz A. Khurram, Kenji M. Fujihara, Brian D. Dynlacht, Timothy J. Cardozo & Richard Possemato. (2023) Allosteric regulation of CAD modulates de novo pyrimidine synthesis during the cell cycle. Nature Metabolism 5:2, pages 277-293.
Crossref
Qiang Zhang, Kaisa Cui, Xiaoya Yang, Qilang He, Jing Yu, Li Yang, Gang Yao, Weiwei Guo, Zhanhao Luo, Yugeng Liu, Yuan Chen, Zhen He & Ping Lan. (2023) c‐Myc–IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming. Clinical and Translational Medicine 13:1.
Crossref
Laura A. Orofiamma, Dafne Vural & Costin N. Antonescu. (2022) Control of cell metabolism by the epidermal growth factor receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1869:12, pages 119359.
Crossref
Adriano Barbosa-Silva, Milena Magalhães, Gilberto Ferreira Da Silva, Fabricio Alves Barbosa Da Silva, Flávia Raquel Gonçalves Carneiro & Nicolas Carels. (2022) A Data Science Approach for the Identification of Molecular Signatures of Aggressive Cancers. Cancers 14:9, pages 2325.
Crossref
Shaimaa Hussein, Pooja Khanna, Neha Yunus & Michael L. Gatza. (2021) Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer. Cancers 13:19, pages 4808.
Crossref
Vincent Tambay, Valérie-Ann Raymond & Marc Bilodeau. (2021) MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype. Cancers 13:17, pages 4484.
Crossref
Wanyan Wang, Jiayan Cui, Hui Ma, Weiqiang Lu & Jin Huang. (2021) Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine. Frontiers in Oncology 11.
Crossref
Timon A. Bloedjes, Guus de Wilde & Jeroen E. J. Guikema. (2021) Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma. Cancers 13:3, pages 396.
Crossref
Tanzina Mollick & Sonia Laín. (2020) Modulating pyrimidine ribonucleotide levels for the treatment of cancer. Cancer & Metabolism 8:1.
Crossref
Yao-An Shen, Jiaxin Hong, Ryoichi Asaka, Shiho Asaka, Fang-Chi Hsu, Yohan Suryo Rahmanto, Jin-Gyoung Jung, Yu-Wei Chen, Ting-Tai Yen, Alicja Tomaszewski, Cissy Zhang, Nabeel Attarwala, Angelo M. DeMarzo, Ben Davidson, Chi-Mu Chuang, Xi Chen, Stephanie Gaillard, Anne Le, Ie-Ming Shih & Tian-Li Wang. (2020) Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers. Cancer Research 80:20, pages 4514-4526.
Crossref
Dirk Mossmann, Sujin Park & Michael N. Hall. (2018) mTOR signalling and cellular metabolism are mutual determinants in cancer. Nature Reviews Cancer 18:12, pages 744-757.
Crossref
Adam J. Wolpaw & Chi V. Dang. (2018) MYC-induced metabolic stress and tumorigenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1870:1, pages 43-50.
Crossref
Ferdinando Chiaradonna, Francesca Ricciardiello & Roberta Palorini. (2018) The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring. Cells 7:6, pages 53.
Crossref
Christopher J Walker, Craig M Rush, Paola Dama, Matthew J O’Hern, Casey M Cosgrove, Jessica L Gillespie, Roman A Zingarelli, Blair Smith, Maggie E Stein, David G Mutch, Reena Shakya, Chia-Wen Chang, Karuppaiyah Selvendiran, Jonathan W Song, David E Cohn & Paul J Goodfellow. (2018) MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization. JNCI: Journal of the National Cancer Institute 110:5, pages 517-526.
Crossref
Kiyotoshi SatohShinichi YachidaMasahiro SugimotoMinoru OshimaToshitaka NakagawaShintaro AkamotoSho TabataKaori SaitohKeiko KatoSaya SatoKaori IgarashiYumi AizawaRie Kajino-SakamotoYasushi KojimaTeruaki FujishitaAyame EnomotoAkiyoshi HirayamaTakamasa IshikawaMakoto Mark Taketo, Yoshio KushidaReiji HabaKeiichi OkanoMasaru TomitaYasuyuki SuzukiShinji FukudaMasahiro AokiTomoyoshi Soga. (2017) Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proceedings of the National Academy of Sciences 114:37.
Crossref
Bjarne Hove-Jensen, Kasper R. Andersen, Mogens Kilstrup, Jan Martinussen, Robert L. Switzer & Martin Willemoës. (2017) Phosphoribosyl Diphosphate (PRPP): Biosynthesis, Enzymology, Utilization, and Metabolic Significance. Microbiology and Molecular Biology Reviews 81:1.
Crossref
Brian C. Grieb, Kelli Boyd, Ramkrishna Mitra & Christine M. Eischen. (2016) Haploinsufficiency of the Myc regulator Mtbp extends survival and delays tumor development in aging mice. Aging 8:10, pages 2590-2602.
Crossref
Annie L. Hsieh & Chi V. Dang. 2016. Metabolism in Cancer. Metabolism in Cancer
73
91
.
Zachary E. Stine, Zandra E. Walton, Brian J. Altman, Annie L. Hsieh & Chi V. Dang. (2015) MYC, Metabolism, and Cancer. Cancer Discovery 5:10, pages 1024-1039.
Crossref
Theresia R. Kress, Arianna Sabò & Bruno Amati. (2015) MYC: connecting selective transcriptional control to global RNA production. Nature Reviews Cancer 15:10, pages 593-607.
Crossref
Therese Wahlström & Marie Arsenian Henriksson. (2015) Impact of MYC in regulation of tumor cell metabolism. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1849:5, pages 563-569.
Crossref
Daniel Diolaiti, Lisa McFerrin, Patrick A. Carroll & Robert N. Eisenman. (2015) Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1849:5, pages 484-500.
Crossref
Arvin M. Gouw, Annie L. Hsieh, Zachary E. Stine & Chi V. Dang. 2015. Tumor Cell Metabolism. Tumor Cell Metabolism
101
122
.
V. M. Merkulov & T. I. Merkulova. (2014) Regulatory transcription factors can control the process of transcription at the stage of pre-mRNA elongation. Russian Journal of Genetics: Applied Research 4:6, pages 549-555.
Crossref
Markus Hartl, Stella GlasauerTaras Valovka, Kathrin Breuker, Bert Hobmayer & Klaus Bister. (2014)
Hydra myc2
, a unique pre-bilaterian member of the
myc
gene family, is activated in cell proliferation and gametogenesis
. Biology Open 3:5, pages 397-407.
Crossref
Lijian Yang, Yan Meng, Chun Bao, Wangheng Liu, Chengzhang Ma, Anbang Li, Zhan Xuan, Ge Shan & Ya Jia. (2013) Robustness and Backbone Motif of a Cancer Network Regulated by miR-17-92 Cluster during the G1/S Transition. PLoS ONE 8:3, pages e57009.
Crossref
Yuki Fujimoto, Yoshikazu Nakamura & Shoji Ohuchi. (2012) HEXIM1-binding elements on mRNAs identified through transcriptomic SELEX and computational screening. Biochimie 94:9, pages 1900-1909.
Crossref
Charles G. Mullighan. 2013. Childhood Leukemias. Childhood Leukemias
168
203
.
Lisa M. Nilsson, Tacha Zi Plym Forshell, Sara Rimpi, Christiane Kreutzer, Walter Pretsch, Georg W. Bornkamm & Jonas A. Nilsson. (2012) Mouse Genetics Suggests Cell-Context Dependency for Myc-Regulated Metabolic Enzymes during Tumorigenesis. PLoS Genetics 8:3, pages e1002573.
Crossref
Tomoyuki Kamigaito, Tadashi Noguchi, Kazunori Narumi, Rie Takashima, Shuichi Hamada, Hisakazu Sanada, Masayuki Hasuko, Hiroyuki Hayashi, Kenichi Masumura & Takehiko Nohmi. (2012) Evaluation of the in vivo Mutagenicity of Nickel Subsulfide in the Lung of F344 gpt delta Transgenic Rats Exposed by Intratracheal Instillation: A Collaborative Study for the gpt delta Transgenic Rat Mutation Assay. Genes and Environment 34:1, pages 34-44.
Crossref
Katannya Kapeli & Peter J. Hurlin. (2011) Differential Regulation of N-Myc and c-Myc Synthesis, Degradation, and Transcriptional Activity by the Ras/Mitogen-activated Protein Kinase Pathway. Journal of Biological Chemistry 286:44, pages 38498-38508.
Crossref
Linus Plym Forshell, Yongmei Li, Tacha Zi Plym Forshell, Martina Rudelius, Lisa Nilsson, Ulrich Keller & Jonas Nilsson. (2011) The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas. Oncotarget 2:6, pages 448-460.
Crossref
Ami Albihn, John Inge Johnsen & Marie Arsenian Henriksson. 2010.
163
224
.
Ping-Yen Chen, Wun-Shaing W. Chang, Yiu-Kay Lai & Cheng-Wen Wu. (2009) c-Myc regulates the coordinated transcription of brain disease-related PDCD10–SERPINI1 bidirectional gene pair. Molecular and Cellular Neuroscience 42:1, pages 23-32.
Crossref
Natalie Meyer & Linda Z. Penn. (2008) Reflecting on 25 years with MYC. Nature Reviews Cancer 8:12, pages 976-990.
Crossref
Guosheng Jiang, Ami Albihn, Tianhua Tang, Zhigang Tian & Marie Henriksson. (2008) Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid. Leukemia Research 32:2, pages 297-307.
Crossref
Xiao-Yong Zhang, Maya Varthi, Stephen M. Sykes, Charles Phillips, Claude Warzecha, Wenting Zhu, Anastasia Wyce, Alan W. Thorne, Shelley L. Berger & Steven B. McMahon. (2008) The Putative Cancer Stem Cell Marker USP22 Is a Subunit of the Human SAGA Complex Required for Activated Transcription and Cell-Cycle Progression. Molecular Cell 29:1, pages 102-111.
Crossref
Philippe P. Luedi, Fred S. Dietrich, Jennifer R. Weidman, Jason M. Bosko, Randy L. Jirtle & Alexander J. Hartemink. (2007) Computational and experimental identification of novel human imprinted genes. Genome Research 17:12, pages 1723-1730.
Crossref
Yasmin SitabkhanAllen Frankfater. (2007) Differences in the Expression of Cathepsin B in B16 Melanoma Metastatic Variants Depend on Transcription Factor Sp1. DNA and Cell Biology 26:9, pages 673-682.
Crossref
Marcus G. Pezzolesi, Kevin M. Zbuk, Kristin A. Waite & Charis Eng. (2007) Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome. Human Molecular Genetics 16:9, pages 1058-1071.
Crossref
S. Rimpi & J.A. Nilsson. (2007)
Metabolic enzymes regulated by the
Myc
oncogene are possible targets for chemotherapy or chemoprevention
. Biochemical Society Transactions 35:2, pages 305-310.
Crossref
Chi V. Dang, Kathryn A. O’Donnell, Karen I. Zeller, Tam Nguyen, Rebecca C. Osthus & Feng Li. (2006) The c-Myc target gene network. Seminars in Cancer Biology 16:4, pages 253-264.
Crossref
Adolfo A. Ferrando, Jeffrey E. Rubnitz & A. Thomas Look. 2010. Childhood Leukemias. Childhood Leukemias
272
297
.
L. A. Lee & C. V. Dang. 2006. The Myc/Max/Mad Transcription Factor Network. The Myc/Max/Mad Transcription Factor Network
145
167
.
Xiao-yong Zhang, Lauren M. DeSalle, Jagruti H. Patel, Anthony J. Capobianco, Duonan Yu, Andrei Thomas-Tikhonenko & Steven B. McMahon. (2005) Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proceedings of the National Academy of Sciences 102:39, pages 13968-13973.
Crossref
G B Willer, V M Lee, R G Gregg & B A Link. (2005)
Analysis of the Zebrafish
perplexed
Mutation Reveals Tissue-Specific Roles for
de Novo
Pyrimidine Synthesis During Development
. Genetics 170:4, pages 1827-1837.
Crossref
Jonas A. Nilsson, Lisa M. Nilsson, Ulrich Keller, Yoshifumi Yokota, Kelli Boyd & John L. Cleveland. (2004) Id2 Is Dispensable for Myc-Induced Lymphomagenesis. Cancer Research 64:20, pages 7296-7301.
Crossref
A. THOMAS LOOK & ADOLFO FERRANDO. 2004. Molecular Biology of B Cells. Molecular Biology of B Cells
349
364
.
Sara K Oster, Daniel Y L Mao, James Kennedy & Linda Z Penn. (2003) Functional analysis of the N-terminal domain of the Myc oncoprotein. Oncogene 22:13, pages 1998-2010.
Crossref
Robert F. Kalejta & Thomas Shenk. (2003)
The Human Cytomegalovirus UL82 Gene Product (pp71) Accelerates Progression through the G
1
Phase of the Cell Cycle
. Journal of Virology 77:6, pages 3451-3459.
Crossref
Kirwin M. Providence, Lisa A. White, Jianzhong Tang, John Gonclaves, Lisa Staiano-Coico & Paul J. Higgins. (2002) Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene. Journal of Cell Science 115:19, pages 3767-3777.
Crossref
Scott R. Eberhardy & Peggy J. Farnham. (2002) Myc Recruits P-TEFb to Mediate the Final Step in the Transcriptional Activation of the cad Promoter. Journal of Biological Chemistry 277:42, pages 40156-40162.
Crossref
John D. Watson, Sara K. Oster, Mary Shago, Fereshteh Khosravi & Linda Z. Penn. (2002) Identifying Genes Regulated in a Myc-dependent Manner. Journal of Biological Chemistry 277:40, pages 36921-36930.
Crossref
Robert G. Harris, Edward White, Emma S. Phillips & Karen A. Lillycrop. (2002) The Expression of the Developmentally Regulated Proto-oncogenePax-3 Is Modulated by N-Myc. Journal of Biological Chemistry 277:38, pages 34815-34825.
Crossref
I Manni, P Tunici, N Cirenei, R Albarosa, B M Colombo, L Roz, A Sacchi, G Piaggio & G Finocchiaro. (2002) Mxi1 inhibits the proliferation of U87 glioma cells through down-regulation of cyclin B1 gene expression. British Journal of Cancer 86:3, pages 477-484.
Crossref
Sara K. Oster, Cynthia S.W. Ho, Erinn L. Soucie & Linda Z. Penn. 2002.
81
154
.
Scott R. Eberhardy & Peggy J. Farnham. (2001) c-Myc Mediates Activation of the cad Promoter via a Post-RNA Polymerase II Recruitment Mechanism. Journal of Biological Chemistry 276:51, pages 48562-48571.
Crossref
Jörgen Bierau, Albert H. van Gennip, Jozien Helleman & André B.P. van Kuilenburg. (2001) The cytostatic- and differentiation-inducing effects of cyclopentenyl cytosine on neuroblastoma cell lines11Abbreviations: CPEC, cyclopentenyl cytosine; and CPECTP, cyclopentenyl cytosine-5′-triphosphate.. Biochemical Pharmacology 62:8, pages 1099-1105.
Crossref
Linda M Boxer & Chi V Dang. (2001) Translocations involving c-myc and c-myc function. Oncogene 20:40, pages 5595-5610.
Crossref
Scott R. Frank, Marianne Schroeder, Paula Fernandez, Stefan Taubert & Bruno Amati. (2001) Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes & Development 15:16, pages 2069-2082.
Crossref
Rheem D Medh, Aixia Wang, Feng Zhou & E Brad Thompson. (2001) Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells. Oncogene 20:34, pages 4629-4639.
Crossref
Jonathan L. HechtJon C. Aster. (2000) Molecular Biology of Burkitt’s Lymphoma. Journal of Clinical Oncology 18:21, pages 3707-3721.
Crossref
Shannon K Hirst & Carla Grandori. (2000) Differential activity of conditional MYC and its variant MYC-S in human mortal fibroblasts. Oncogene 19:45, pages 5189-5197.
Crossref
Sunkyu Kim, Qing Li, Chi V. Dang & Linda A. Lee. (2000)
Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc
in vivo
. Proceedings of the National Academy of Sciences 97:21, pages 11198-11202.
Crossref
Alexander Pajic, Dimitry Spitkovsky, Barbara Christoph, Bettina Kempkes, Marino Schuhmacher, Martin S. Staege, Markus Brielmeier, Joachim Ellwart, Franz Kohlhuber, Georg W. Bornkamm, Axel Polack & Dirk Eick. (2000) Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. International Journal of Cancer 87:6, pages 787-793.
Crossref
M Landay, S K Oster, F Khosravi, L E Grove, X Yin, J Sedivy, L Z Penn & E V Prochownik. (2000) Promotion of growth and apoptosis in c-myc nullizygous fibroblasts by other members of the myc oncoprotein family. Cell Death & Differentiation 7:8, pages 697-705.
Crossref
Katrien Berns, E Marielle Hijmans, Eugene Koh, George Q Daley & René Bernards. (2000) A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts. Oncogene 19:29, pages 3330-3334.
Crossref
Ellen G Vernon & Kevin Gaston. (2000) Myc and YY1 mediate activation of the Surf-1 promoter in response to serum growth factors. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1492:1, pages 172-179.
Crossref
Hirotake Kitaura, Minako Shinshi, Yasuko Uchikoshi, Takashi Ono, Toshiki Tsurimoto, Hiroshi Yoshikawa, Sanae M.M. Iguchi-Ariga & Hiroyoshi Ariga. (2000) Reciprocal Regulation via Protein-Protein Interaction between c-Myc and p21 in DNA Replication and Transcription. Journal of Biological Chemistry 275:14, pages 10477-10483.
Crossref
Stefanie Gehring, Sabine Rottmann, Annette R. Menkel, Jürgen Mertsching, Anja Krippner-Heidenreich & Bernhard Lüscher. (2000) Inhibition of Proliferation and Apoptosis by the Transcriptional Repressor Mad1. Journal of Biological Chemistry 275:14, pages 10413-10420.
Crossref
Takeshi Niki, Sachiyo Izumi, Yumiko Saëgusa, Takahiro Taira, Toshiki Takai, Sanae M. M. Iguchi-Ariga & Hiroyoshi Ariga. (2000) MSSP promotes ras/myc cooperative cell transforming activity by binding to c-Myc. Genes to Cells 5:2, pages 127-141.
Crossref
Susanna M. Mac & Peggy J. Farnham. (2000) CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines. Molecular Carcinogenesis 27:2, pages 84-96.
Crossref
Chang Ming FANG, Can SHI & Yong Hua XU. (1999) Deregulated c-myc expression in quiescent CHO cells induces target gene transcription and subsequent apoptotic phenotype. Cell Research 9:4, pages 305-314.
Crossref
Chi V. Dang, Linda M.S. Resar, Eileen Emison, Sunkyu Kim, Qing Li, Julia E. Prescott, Diane Wonsey & Karen Zeller. (1999) Function of the c-Myc Oncogenic Transcription Factor. Experimental Cell Research 253:1, pages 63-77.
Crossref
Penelope L Davis, Alexander Miron, Leisha M Andersen, J Dirk Iglehart & Jeffrey R Marks. (1999) Isolation and initial characterization of the BRCA2 promoter. Oncogene 18:44, pages 6000-6012.
Crossref
Amir Eden & Nissim Benvenisty. (1999)
Involvement of branched-chain amino acid aminotransferase (
Bcat1
/
Eca39
) in apoptosis
. FEBS Letters 457:2, pages 255-261.
Crossref
Bernhard Lüscher & Lars-Gunnar Larsson. (1999) The basic region/helix – loop – helix/leucine zipper domain of Myc proto-oncoproteins: Function and regulation. Oncogene 18:19, pages 2955-2966.
Crossref
Michael D Cole & Steven B McMahon. (1999) The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18:19, pages 2916-2924.
Crossref
George C Prendergast. (1999) Mechanisms of apoptosis by c-Myc. Oncogene 18:19, pages 2967-2987.
Crossref
Andrew Bush, Maria Mateyak, Kerri Dugan, Alvaro Obaya, Susumu Adachi, John Sedivy & Michael Cole. (1998)
c-
myc
null cells misregulate
cad
and
gadd45
but not other proposed c-Myc targets
. Genes & Development 12:24, pages 3797-3802.
Crossref
Thomas P Neufeld & Bruce A Edgar. (1998) Connections between growth and the cell cycle. Current Opinion in Cell Biology 10:6, pages 784-790.
Crossref
Kathryn E. Boyd, Julie Wells, Julie Gutman, Stephanie M. Bartley & Peggy J. Farnham. (1998) c-Myc target gene specificity is determined by a post-DNAbinding mechanism. Proceedings of the National Academy of Sciences 95:23, pages 13887-13892.
Crossref
Katsuhiro Mori, Yuichi Maeda, Hirotake Kitaura, Takahiro Taira, Sanae M.M. Iguchi-Ariga & Hiroyoshi Ariga. (1998) MM-1, a Novel c-Myc-associating Protein That Represses Transcriptional Activity of c-Myc. Journal of Biological Chemistry 273:45, pages 29794-29800.
Crossref
Mark G. Alexandrow & Harold L. Moses. (1998) c-Myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. Journal of Cellular Biochemistry 70:4, pages 528-542.
Crossref
Takahiro TairaJunko MaëdaTakako OnishiHirotake KitauraShu YoshidaHiroyuki KatoMasako Ikeda, Katsuyuki Tamai, Sanae M. M. Iguchi‐ArigaHiroyoshi Ariga. (2002) AMY‐1, a novel C‐MYC binding protein that stimulates transcription activity of C‐MYC. Genes to Cells 3:8, pages 549-565.
Crossref
Linda M. Facchini & Linda Z. Penn. (1998) The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. The FASEB Journal 12:9, pages 633-651.
Crossref
A.J.M Walhout, P.C van der Vliet & H.Th.M Timmers. (1998) Sequences flanking the E-box contribute to cooperative binding by c-Myc/Max heterodimers to adjacent binding sites. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1397:2, pages 189-201.
Crossref
Anette Sommer, Kristine Bousset, Elisabeth Kremmer, Matthias Austen & Bernhard Lüscher. (1998) Identification and Characterization of Specific DNA-binding Complexes Containing Members of the Myc/Max/Mad Network of Transcriptional Regulators. Journal of Biological Chemistry 273:12, pages 6632-6642.
Crossref
Alvin Berger, Constance M. Cultaro, Shoshana Segal & Sarah Spiegel. (1998) The potent lipid mitogen sphingosylphosphocholine activates the DNA binding activity of upstream stimulating factor (USF), a basic helix-loop-helix-zipper protein. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1390:2, pages 225-236.
Crossref
Martine F. Roussel. 1998.
1
24
.
L. Yamasaki. 1998. Cell Cycle Control. Cell Cycle Control
199
227
.
A. Bürgin, C. Bouchard & M. Eilers. 1998. Cell Cycle Control. Cell Cycle Control
181
197
.
Theodore C. Lee, Linheng Li, Lennart Philipson & Edward B. Ziff. (1997)
Myc represses transcription of the growth arrest gene
gas1
. Proceedings of the National Academy of Sciences 94:24, pages 12886-12891.
Crossref
HONGBING WANG, FRANCOISE VAN DEN BERGH, ERIKA SPENCER, KENT WILCOX & TIM HERMAN. (1997) Use of a Two-Hybrid System to Identify Mutations in Max That Confer Increased Affinity for Myc. DNA and Cell Biology 16:11, pages 1277-1288.
Crossref
Chi V. Dang & Brian C. Lewis. (1997) Role of oncogenic transcription factor c-Myc in cell cycle regulation, apoptosis and metabolism. Journal of Biomedical Science 4:6, pages 269-278.
Crossref
Hyunsuk Shim, Christine Dolde, Brian C. Lewis, Chyi-Sun Wu, Gerard Dang, Richard A. Jungmann, Riccardo Dalla-Favera & Chi V. Dang. (1997)
c-Myc transactivation of
LDH-A
: Implications for tumor metabolism and growth
. Proceedings of the National Academy of Sciences 94:13, pages 6658-6663.
Crossref
OLIVER PUSCH, THOMAS SOUCEK, ELKE HENGSTSCHLÄGER-OTTNAD, GERHARD BERNASCHEK & MARKUS HENGSTSCHLÄGER. (1997) Cellular Targets for Activation by c-Myc Include the DNA Metabolism Enzyme Thymidine Kinase. DNA and Cell Biology 16:6, pages 737-747.
Crossref
Sharyl J. Nass & Robert B. Dickson. (1997) Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Research and Treatment 44:1, pages 1-22.
Crossref
Robin Hesketh. 1997. The Oncogene & Tumour Suppressor Gene Factsbook. The Oncogene & Tumour Suppressor Gene Factsbook
287
301
.
H. Shim, B. C. Lewis, C. Dolde, Q. Li, C.-S. Wu, Y. S. Chun & C. V. Dang. 1997. C-Myc in B-Cell Neoplasia. C-Myc in B-Cell Neoplasia
181
190
.
George C. Prendergast. 1997. Oncogenes as Transcriptional Regulators. Oncogenes as Transcriptional Regulators
1
28
.
Emmett V. Schmidt. (1996) MYC family ties. Nature Genetics 14:1, pages 8-10.
Crossref
L Desbarats, S Gaubatz & M Eilers. (1996) Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.. Genes & Development 10:4, pages 447-460.
Crossref
Jean-Marc Lemaitre, Robin S. Buckle & Marcel Méchali. 1996.
95
144
.
Marie Henriksson & Bernhard Lüscher. 1996.
109
182
.
P. J. Farnham. 1996. Transcriptional Control of Cell Growth. Transcriptional Control of Cell Growth
129
137
.
Jill E. Slansky & Peggy J. Farnham. (1996) Transcriptional regulation of the dihydrofolate reductase gene. BioEssays 18:1, pages 55-62.
Crossref
Chi V. Dang & Linda A. LeeChi V. Dang & Linda A. Lee. 1995. c-Myc Function in Neoplasia. c-Myc Function in Neoplasia
171
192
.